Table 1.
Formulation | Composition | ||
---|---|---|---|
HPβCD (w/v, %) | Tacrolimus (w/v, %) | Vehicles | |
TBS 20 | 20 | 0.01 | BSS® |
TLI 20 | 20 | 0.01 | Liquifilm® |
TBS 40 | 40 | 0.02 | BSS® |
TLI 40 | 40 | 0.02 | Liquifilm® |
REF | - | 0.03 | Liquifilm® |
Formulation | Composition | ||
---|---|---|---|
HPβCD (w/v, %) | Tacrolimus (w/v, %) | Vehicles | |
TBS 20 | 20 | 0.01 | BSS® |
TLI 20 | 20 | 0.01 | Liquifilm® |
TBS 40 | 40 | 0.02 | BSS® |
TLI 40 | 40 | 0.02 | Liquifilm® |
REF | - | 0.03 | Liquifilm® |